Physician profile
Robert T Casanova
NPI 1225097512
$2,592.29
in general payments reported to CMS, 2019-2025
20 companies · $436 in 2025
The $436 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $219 · 2021: $313 · 2022: $532 · 2023: $116 · 2024: $548 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $923.18 | 2021-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb Americas INC. | $321.88 | 2022-2025 | Envista Mx60 Iol, Scoutpro Osmolarity System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $256.70 | 2019-2020 | |
| Omeros Corporation | $169.08 | 2019-2020 | |
| Iridex Corporation | $119.19 | 2022-2024 | |
| Optovue, INC. | $106.35 | 2019 | |
| Aerie Pharmaceuticals, INC. | $79.94 | 2019-2021 | |
| Alcon Vision LLC | $76.14 | 2025 | Clareon |
| Johnson & Johnson Surgical Vision, INC. | $71.43 | 2024 | Catalys System |
| Visionix USA, INC | $67.84 | 2022 | |
| Rayner Intraocular Lenses Limited | $67.17 | 2022-2023 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Harrow Eye, LLC | $63.54 | 2024 | Iheezo |
| Allergan, INC. | $60.72 | 2020-2022 | |
| Abbvie INC. | $54.22 | 2025 | |
| Novartis Pharmaceuticals Corporation | $47.06 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $39.91 | 2019 | |
| Astellas Pharma US INC | $20.12 | 2024 | Izervay |
| Horizon Therapeutics Plc | $16.74 | 2022 | |
| Ocular Therapeutix, INC. | $16.25 | 2024 | Dextenza |
| Sun Pharmaceutical Industries INC. | $14.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Casanova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.